
HYPR
USDHyperfine Inc. Class A Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$0.788
Максимум
$0.790
Минимум
$0.750
Объем
0.00M
Фундаментальные показатели компании
Рыночная капитализация
60.4M
Отрасль
Медицинские приборы
Страна
United States
Статистические данные торговли
Средний объем
1.19M
Биржа
NGM
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 22 апр. 2025 г.[HYPR: Hyperfine Inc. Class A Common Stock]: Checking the Pulse - What's Next for HYPR?
Stock Symbol: HYPR Generate Date: 2025-04-22 06:38:20
Alright, let's take a look at Hyperfine (HYPR), a company making waves in medical imaging with their portable MRI tech. We've got some news, price history, and even what the AI is predicting. Let's break it down without the jargon.
Recent News Buzz: A Bit of a Mixed Bag
So, what's the chatter around Hyperfine been like? It's interesting. On one hand, we've got analysts at places like Lake Street and B. Riley saying "Buy." That's generally a good sign, right? They see potential. Lake Street even set a target of $1.50. Wells Fargo is a bit more neutral, saying "Equal-Weight," but they did raise their price target a bit to $1.29.
However, here's the twist: B. Riley lowered their price target from $1.50 to $1.20, even while keeping their "Buy" rating. That's a little like saying "We like it, but maybe not quite as much as we thought." It could mean they still believe in the company long-term, but see some near-term bumps in the road.
Then there's news about their financial results and a collaboration with NVIDIA. Teaming up with NVIDIA, especially for AI in medical imaging, sounds pretty smart. That's the kind of thing that could really push their technology forward. The financial results announcement itself is pretty standard, but the NVIDIA news is definitely a positive signal for innovation and future growth.
Overall vibe? It's not screaming "slam dunk," but it's definitely not doom and gloom either. Think of it as cautiously optimistic. Analysts see potential, especially with their tech, but there might be some questions or adjustments happening behind the scenes, hinted at by the price target changes.
Price Check: Bouncing Around Down Low
Now, what's the stock price been doing? Looking back at the last month or so, it's been a bit of a rollercoaster, but mostly trending downwards after a big spike. Let's paint a picture:
- Early February: HYPR was actually on a bit of a hot streak, jumping up to around $1.70 at one point! Lots of action and big trading volumes.
- Mid-February onwards: Things cooled off fast. The price started dropping, and by mid-March, it was back under $1.00.
- Around March 17th: BOOM! Huge volume and a price jump up to $1.33. This likely coincides with the news releases we saw.
- Post-Spike Drop: Just as quickly as it went up, it came back down. The price has been steadily declining since then, hitting lows in the $0.60s recently.
- Current Situation: Right now, HYPR is hovering around $0.70. It's definitely in a lower range compared to where it was even a month ago.
Compared to predictions? The AI is predicting a jump in price soon. It's saying it could go up to $0.95, then $0.97, and then even higher to $2.12 in the next couple of days. That's a pretty bold prediction, especially considering the recent downward trend. It's definitely something to watch closely.
Outlook & Strategy Ideas: Wait and See, But Keep an Eye Out
Putting it all together, what's the takeaway here? It's a bit of a mixed signal situation.
- The Good: Analyst "Buy" ratings, innovative tech (portable MRI, AI collaboration), and AI price predictions suggesting a potential bounce. The recommendation data also leans bullish, highlighting technical indicators and undervaluation.
- The Not-So-Good: Price target reductions by some analysts, recent price downtrend, and the fact that the stock is trading near its 52-week low. Fundamental data is also mixed with negative growth and low ROE, despite the low P/E.
So, what to do? Right now, the situation seems to lean towards cautious observation. It's probably not the time to jump in headfirst, but definitely not time to completely ignore HYPR either.
Potential Entry Consideration (If you're feeling a bit bullish): If you're intrigued by the AI prediction and the "Buy" ratings, keeping an eye on the $0.70 area might be interesting. The recommendation data even points to $0.69-$0.70 as potential entry points. If the price shows signs of holding around this level or starts to tick upwards, and if you see some positive price action confirming the AI's prediction, then a small, speculative entry might be considered. But again, be cautious.
Potential Exit/Stop-Loss Consideration: If you were to enter, setting a stop-loss is crucial, especially with a volatile stock like this. The recommendation data suggests a stop-loss around $0.63. This makes sense as it's below recent lows and would help limit potential losses if the price continues to fall. For taking profits, the $0.79 level is mentioned as a take-profit target in the recommendation data, and the AI prediction of a jump to $0.95-$0.97 and even $2.12 gives potential upside targets to watch if the price starts moving up.
Important Note: These are just potential ideas based on the data. The AI predictions are just predictions, not guarantees. Analyst ratings can change. Stock prices can be unpredictable, especially for smaller companies.
Company Context: Small Cap, Big Tech Ambitions
One last thing to remember: Hyperfine is a relatively small company in the medical device space. They're trying to disrupt traditional MRI with portable, AI-powered technology. That's a big ambition, and it comes with risks and potential rewards. News about their technology, partnerships (like NVIDIA), and regulatory approvals will likely be key drivers for this stock. Being in the healthcare sector and focusing on AI are both hot areas right now, which could be tailwinds for HYPR if they execute well.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Связанные новости
Lake Street Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $1.5
Lake Street analyst Frank Takkinen initiates coverage on Hyperfine with a Buy rating and announces Price Target of $1.5.
B. Riley Securities Maintains Buy on Hyperfine, Lowers Price Target to $1.2
B. Riley Securities analyst Yuan Zhi maintains Hyperfine with a Buy and lowers the price target from $1.5 to $1.2.
Wells Fargo Maintains Equal-Weight on Hyperfine, Raises Price Target to $1.29
Wells Fargo analyst Larry Biegelsen maintains Hyperfine with a Equal-Weight and raises the price target from $1.1 to $1.29.
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation
Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 27 апр. 2025 г., 23:01
61.1% Уверенность
Риск и торговля
Точка входа
$0.76
Взять прибыль
$0.79
Остановить убытки
$0.68
Ключевые факторы
Связанные акции

KYN
Kayne Anderson Energy Infrastructure Fund Inc.

CVLG
Covenant Logistics Group Inc.

NEWTG
NewtekOne Inc. 8.50% Fixed Rate Senior Notes due 2029

FBIOP
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

IAC
IAC Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.